Prevention of cisplatin-induced emesis by a neurokinin-1-receptor antagonist
Roila, F.; Ballatori, E.; Del Favero, A.
New England Journal of Medicine 340(24): 1926-1928
1999
ISSN/ISBN: 0028-4793 PMID: 10375317 Document Number: 511404
Document emailed within 1 workday
Related Documents
Bhandari, P.; Gupta, Y.K.; Seth, S.D. 1989: BRL 43694, a new 5HT3 receptor antagonist, prevents cisplatin-induced emesis in dogs Methods and Findings in Experimental and Clinical Pharmacology 11(5): 361-363Furukawa, N.; Fukuda, H.; Hatano, M.; Koga, T.; Shiroshita, Y. 1998: A neurokinin-1 receptor antagonist reduced hypersalivation and gastric contractility related to emesis in dogs American Journal of Physiology 275(5): G1193-G1201
Hunter, A.E.; Prentice, H.G.; Pothecary, K.; Coumar, A.; Collis, C.; Upward, J.; Murdoch, R.; Gandhi, L.; Hamon, M.; Butler, M. 1991: Granisetron, a selective 5-HT3 receptor antagonist, for the prevention of radiation induced emesis during total body irradiation Bone Marrow Transplantation 7(6): 439-441
Endo, T.; Sugawara, J.; Nemoto, M.; Minami, M.; Blower, P.R. 1998: Effects of granisetron, a selective 5-HT3 receptor antagonist, on ouabain-induced emesis in ferrets Research Communications in Molecular Pathology and Pharmacology 102(3): 227-239
Roila, F.; Tonato, M.; Ballatori, E.; Del Favero, A. 1992: Prevention of cisplatin-induced emesis. The Italian Group for Antiemetic Research Lancet 340(8825): 972
Voravud, N.; Suwanrusmee, H. 2000: Phase II trial of tropisetron and dexamethasone in the prevention of cisplatin-induced emesis Journal of the Medical Association of Thailand 83(6): 668-675
Agostinucci, W.A.; Gannon, R.H.; Golub, G.R.; Martin, R.S.; Schauer, P.K.; Dinonno, E.B. 1988: Continuous i.v. infusion versus multiple bolus doses of metoclopramide for prevention of cisplatin-induced emesis Clinical Pharmacy 7(6): 454-457
Tantipalakorn, C.; Srisomboon, J.; Thienthong, H.; Pantusart, A.; Suprasert, P.; Saereesongkhun, C.; Eamtang, S.; Sutthichat, A.; Pautad, N. 2004: Comparison of oral versus intravenous ramosetron in prevention of acute cisplatin-induced emesis: a randomized controlled trial Journal of the Medical Association of Thailand 87(2): 119-125
Garcia-del-Muro, X.; Vadell, C.; Pérez Manga, G.; Bover, I.; Rifá, J.; Beltrán, M.; Barros, M.M.; Germá, J.R.; Fabregat, X.; Moreno, V.; Salvador, A.; Viladiu, P. 1998: Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis European Journal of Cancer 34(1): 193-195
Endo, T.; Ogawa, T.; Hamaue, N.; Akita, K.; Hirafuji, M.; Minami, M.; Blower, P.R. 1998: Granisetron, a 5-HT3 receptor antagonist, inhibited cisplatin-induced 5-hydroxytryptamine release in the isolated ileum of ferrets Research Communications in Molecular Pathology and Pharmacology 100(3): 243-253
Gylys, J.A.; Doran, K.M.; Buyniski, J.P. 1979: Antagonism of cisplatin induced emesis in the dog Research Communications in Chemical Pathology and Pharmacology 23(1): 61-68
Li, Y.T.; Mau, Y.K.; Hsu, K.P. 1991: Control of cisplatin-induced delayed emesis Zhonghua Yi Xue Za Zhi 48(6): 451-455
Heron, J.F. 1995: Single-agent oral granisetron for the prevention of acute cisplatin-induced emesis: a double-blind, randomized comparison with granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone Seminars in Oncology 22(4 Suppl. 10): 24-30
Ito, J.; Okada, M.; Abo, T.; Okamoto, Y.; Yamashita, T.; Takahashi, K. 1987: Experimental study on the control of cisplatin-induced emesis in dogs Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(3 Part 1): 706-710
Endo, T.; Hamaue, N.; Ihira, E.; Teramoto, Y.; Liu, Y.; Hirafuji, M.; Minami, M. 2002: Effects of granisetron, a 5-HT3 receptor antagonist, on 5-hydroxytryptamine (5-HT) release from the isolated ileum in a delayed-emesis rat model Research Communications in Molecular Pathology and Pharmacology 111(1-4): 55-68
Cupissol, D.R.; Serrou, B.; Caubel, M. 1990: The efficacy of granisetron as a prophylactic anti-emetic and intervention agent in high-dose cisplatin-induced emesis European Journal of Cancer 26(Suppl 1): S23-S27
Bhatia, A.; Tripathi, K.D.; Sharma, M. 2003: Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy Indian Journal of Medical Research 118: 33-41
Huo, M.L.; Wang, Y.S.; Wang, P.; Xiang, Y.S.; Wang, J.G. 1986: Emesis induced by cisplatin and sulfato-1, sulfato-1,2-diaminocyclohexane platinum in dogs and their antiemetics Zhongguo Yao Li Xue Bao 7(2): 182-184
Regidor, P.A.; Nelken, B.; Regidor, M.; Bier, U.; Oberhoff, C.; Schindler, A.E. 1996: Effectiveness and tolerance of Navoban (5HT3-receptor antagonist tropisetron) in prevention of cytostatic drug-induced nausea and vomiting in patients with breast carcinomas and gynecological malignancies Zentralblatt für Gynakologie 118(3): 148-153
Hellenbrecht, D.; Saller, R. 1986: Dose-response relationships of the objective and subjective antiemetic effects and of different side effects of metoclopramide against cisplatin induced emesis Arzneimittel-Forschung 36(12): 1845-1849